000 01576 a2200421 4500
005 20250511131546.0
264 0 _c19800226
008 198002s 0 0 eng d
022 _a0026-0495
024 7 _a10.1016/0026-0495(79)90141-0
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBreslau, N A
245 0 0 _aHypoparathyroidism.
_h[electronic resource]
260 _bMetabolism: clinical and experimental
_cDec 1979
300 _a1261-76 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.; Review
650 0 4 _aAcetazolamide
_xtherapeutic use
650 0 4 _aAdenylyl Cyclases
_xmetabolism
650 0 4 _aAntacids
_xtherapeutic use
650 0 4 _aBone and Bones
_xpathology
650 0 4 _aCalcium
_xtherapeutic use
650 0 4 _aChlorthalidone
_xtherapeutic use
650 0 4 _aDihydroxycholecalciferols
_xmetabolism
650 0 4 _aDrug Resistance
650 0 4 _aHumans
650 0 4 _aHypocalcemia
_xphysiopathology
650 0 4 _aHypoparathyroidism
_xclassification
650 0 4 _aKidney Failure, Chronic
_xphysiopathology
650 0 4 _aMagnesium Deficiency
650 0 4 _aParathyroid Hormone
_xmetabolism
650 0 4 _aPostoperative Complications
650 0 4 _aPseudohypoparathyroidism
_xphysiopathology
650 0 4 _aQuaternary Ammonium Compounds
_xtherapeutic use
650 0 4 _aVitamin D
_xmetabolism
700 1 _aPak, C Y
773 0 _tMetabolism: clinical and experimental
_gvol. 28
_gno. 12
_gp. 1261-76
856 4 0 _uhttps://doi.org/10.1016/0026-0495(79)90141-0
_zAvailable from publisher's website
999 _c411285
_d411285